Sleep Aids (Pharmacies) - GCC | Statista Market Forecast

Revenue in the Sleep Aids market is projected to reach US$21.32m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.01%, resulting in a market volume of US$21.34m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.35 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in GCC is witnessing significant growth and development in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this positive trajectory.

Customer preferences: Customers in the GCC region are increasingly prioritizing their sleep health and seeking solutions to improve their sleep quality. This shift in customer preferences can be attributed to several factors, including the fast-paced and stressful lifestyles in urban areas, the prevalence of sleep disorders, and the growing awareness of the importance of sleep for overall well-being. As a result, there is a rising demand for sleep aids in pharmacies, such as over-the-counter sleep medications, herbal remedies, and sleep-inducing devices.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in GCC is the increasing availability and variety of sleep aids in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for sleep aids, ensuring that customers have access to a wide range of options to address their specific sleep issues. Additionally, there is a growing trend towards natural and herbal sleep aids, as customers are increasingly seeking safer and more sustainable alternatives to traditional medications.

Local special circumstances: The unique cultural and social circumstances in the GCC region also play a role in shaping the Sleep Aids (Pharmacies) market. The region has a high prevalence of sleep disorders, which can be attributed to factors such as extreme weather conditions, irregular work schedules, and cultural practices that may disrupt sleep patterns. These local circumstances have created a need for effective sleep aids that can help individuals overcome these challenges and achieve restful sleep.

Underlying macroeconomic factors: Several macroeconomic factors contribute to the development of the Sleep Aids (Pharmacies) market in the GCC region. The region's growing population, increasing urbanization, and rising disposable incomes are driving the demand for sleep aids. Furthermore, the GCC countries have robust healthcare systems, with a strong emphasis on preventive and holistic healthcare. This focus on overall well-being and the recognition of the importance of sleep as a key pillar of health have further fueled the demand for sleep aids in pharmacies. In conclusion, the Sleep Aids (Pharmacies) market in GCC is experiencing significant growth and development due to shifting customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. As customers in the region prioritize their sleep health, pharmacies are expanding their offerings to meet the growing demand for sleep aids. The unique cultural and social circumstances in the GCC region, coupled with favorable macroeconomic factors, further contribute to the positive trajectory of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.